WCPO: UC scientist finds new solution to fight superbug infections
Professor Hassett takes on some of the nastiest infections resistant to antibiotics
Journalist Paulo Suro speaks with Daniel Hassett, PhD, professor in the UC Department of Molecular Genetics, Biochemistry and Microbiology, about his patented treatment AB569 and its possible use to treat cystic fibrosis, chronic obstructive pulmonary disease and other infections. AB569 tackles some of the nastiest superbugs on the planet and currently being tested in human trials to ensure its safety for future patients.
Related Stories
University of Cincinnati gets $1.1M for AI physician training
January 30, 2026
The University of Cincinnati College of Medicine has received a four-year, $1.1 million grant to explore using artificial intelligence and personalized learning to improve physician education.
UC to launch first student-led satellite with NASA
January 30, 2026
The University of Cincinnati’s CubeCats team handed NASA its first student-built satellite, the LEOPARDSat-1, which will head to the International Space Station in spring 2026.
University of Cincinnati takes center stage as sponsor of SXSW 2026 Workplace Track
January 30, 2026
Discover how the University of Cincinnati is shaping the future of work as the official sponsor of SXSW 2026’s Workplace Track. Explore UC’s innovation-driven approach, industry partnerships, and student success stories at the forefront of global workforce evolution, March 12–18 in Austin, Texas.